Terms: = Breast cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Prognosis
1244 results:
1. Stable feature selection utilizing Graph Convolutional Neural Network and Layer-wise Relevance Propagation for biomarker discovery in breast cancer.
Chereda H; Leha A; Beißbarth T
Artif Intell Med; 2024 May; 151():102840. PubMed ID: 38658129
[TBL] [Abstract] [Full Text] [Related]
2. Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment.
Liu L; Zhang M; Cui N; Liu W; Di G; Wang Y; Xi X; Li H; Shen Z; Gu M; Wang Z; Jiang S; Liu B
PLoS One; 2024; 19(4):e0298004. PubMed ID: 38635528
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive bioinformatics analysis unveils THEMIS2 as a carcinogenic indicator related to immune infiltration and prognosis of thyroid cancer.
Liu JF; Zou B; Xiang C; Yan HC
Sci Rep; 2024 Apr; 14(1):8156. PubMed ID: 38589421
[TBL] [Abstract] [Full Text] [Related]
4. Construction and validation of a hypoxia-related gene signature to predict the prognosis of breast cancer.
Qiu C; Wang W; Xu S; Li Y; Zhu J; Zhang Y; Lei C; Li W; Li H; Li X
BMC Cancer; 2024 Apr; 24(1):402. PubMed ID: 38561760
[TBL] [Abstract] [Full Text] [Related]
5. Development and validation of a nomogram for predicting lymph node metastasis in ductal carcinoma in situ with microinvasion: A SEER population-based study.
Zhu K; Sui Y; Zhu M; Gao Y; Yuan Y; Sun P; Meng L; Dai J; Li Z
PLoS One; 2024; 19(4):e0301057. PubMed ID: 38557552
[TBL] [Abstract] [Full Text] [Related]
6. Novel prognostic biomarker TBC1D1 is associated with immunotherapy resistance in gliomas.
Song D; Yang Q; Li L; Wei Y; Zhang C; Du H; Ren G; Li H
Front Immunol; 2024; 15():1372113. PubMed ID: 38529286
[TBL] [Abstract] [Full Text] [Related]
7. Construction of an oxidative stress-associated genes signature in breast cancer by machine learning algorithms.
Hu D; Qin B; Zhang L; Bu H
J Int Med Res; 2024 Mar; 52(3):3000605241232560. PubMed ID: 38520254
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive evaluation of the relationship between biomarker profiles and neoadjuvant chemotherapy outcomes for breast cancer patients.
Wang M; Wei Z; Kong J; Zhao H
Diagn Pathol; 2024 Mar; 19(1):53. PubMed ID: 38509525
[TBL] [Abstract] [Full Text] [Related]
9. Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer.
Godina C; Belting M; Vallon-Christersson J; Isaksson K; Bosch A; Jernström H
Sci Rep; 2024 Mar; 14(1):6675. PubMed ID: 38509243
[TBL] [Abstract] [Full Text] [Related]
10. Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma.
Zhu J; Zhao W; Yang J; Liu C; Wang Y; Zhao H
Anticancer Drugs; 2024 Jun; 35(5):466-480. PubMed ID: 38507233
[TBL] [Abstract] [Full Text] [Related]
11. Correlation between S100A7 and immune characteristics, methylation, tumor stemness and tumor heterogeneity in pan-cancer and its role in chemotherapy resistance in breast cancer.
Li Y; Yang X; Jin T; Li Q; Li X; Ma L
Aging (Albany NY); 2024 Mar; 16(6):5581-5600. PubMed ID: 38499391
[TBL] [Abstract] [Full Text] [Related]
12. Unraveling Biomarker Signatures in Triple-Negative breast cancer: A Systematic Review for Targeted Approaches.
Pastena P; Perera H; Martinino A; Kartsonis W; Giovinazzo F
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473804
[TBL] [Abstract] [Full Text] [Related]
13. B-Cell-Mediated Immunity Predicts Survival of Patients With Estrogen Receptor-Positive breast cancer.
Lee S; Kang BH; Lee HB; Jang BS; Han W; Kim IA
JCO Precis Oncol; 2024 Mar; 8():e2300263. PubMed ID: 38452311
[TBL] [Abstract] [Full Text] [Related]
14. Construction and Analysis of a Mitochondrial Metabolism-Related Prognostic Model for breast cancer to Evaluate Survival and Immunotherapy.
Lin Y; Huang Z; Zhang B; Yang H; Yang S
J Membr Biol; 2024 Apr; 257(1-2):63-78. PubMed ID: 38441572
[TBL] [Abstract] [Full Text] [Related]
15. Research and experimental verification on the mechanisms of cellular senescence in triple-negative breast cancer.
Cao T; Huang M; Huang X; Tang T
PeerJ; 2024; 12():e16935. PubMed ID: 38435998
[TBL] [Abstract] [Full Text] [Related]
16. Identification of a Group of Therapeutic Targets and Prognostic Biomarker for Triple Negative breast cancer.
Li Y; Yang S; Qi L; Li Y; Wang X
Adv Ther; 2024 Apr; 41(4):1621-1636. PubMed ID: 38421558
[TBL] [Abstract] [Full Text] [Related]
17. Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker.
Yang W; Liu Z; Liu T
Cell Signal; 2024 May; 117():111107. PubMed ID: 38369265
[TBL] [Abstract] [Full Text] [Related]
18. Low expression of fatty acid oxidation related gene ACADM indicates poor prognosis of renal clear cell carcinoma and is related to tumor immune infiltration.
Qiu J; Yang T; Sun Y; Sun K; Xu Y; Xia Q
Oncol Res; 2024; 32(3):545-561. PubMed ID: 38361759
[TBL] [Abstract] [Full Text] [Related]
19. Discovery of a proliferation essential gene signature and actin-like 6A as potential biomarkers for predicting prognosis and neoadjuvant chemotherapy response in triple-positive breast cancer.
Li X; Luo S; Fu W; Huang M; Huang X; Kang S; Zhang J; Wang Q; Song C
Cancer; 2024 Apr; 130(S8):1435-1448. PubMed ID: 38358781
[TBL] [Abstract] [Full Text] [Related]
20. Identification and validation of a copper homeostasis-related gene signature for the predicting prognosis of breast cancer patients via integrated bioinformatics analysis.
Li Y; Wei X; Wang Y; Wang W; Zhang C; Kong D; Liu Y
Sci Rep; 2024 Feb; 14(1):3141. PubMed ID: 38326441
[TBL] [Abstract] [Full Text] [Related]
[Next]